Description

7-Bromo-1-(4-Hydroxy-2-Methylphenyl)-4-Oxo-1,4-Dihydroquinoline-3-Carboxamide is a high-purity, advanced pharmaceutical intermediate designed for research and development in modern drug discovery. This compound is valued for its role as a key synthetic building block in the creation of novel therapeutic agents, particularly within the quinoline class of molecules. It is primarily utilized by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers targeting innovative drug candidates.

Application

• Pharmaceutical Intermediate: A critical building block in the synthesis of novel quinoline-based active pharmaceutical ingredients (APIs) for therapeutic applications.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new drug discovery programs.
• Chemical Biology Probes: Serves as a precursor for developing molecular probes to study biological pathways and enzyme functions.
• Custom Synthesis: Employed by fine chemical suppliers for the contract manufacturing of complex, high-value specialty chemicals.
• Academic Research: Utilized in university and institutional laboratories for advanced organic synthesis and heterocyclic chemistry studies.

Basic Information

Product Name	7-Bromo-1-(4-Hydroxy-2-Methylphenyl)-4-Oxo-1,4-Dihydroquinoline-3-Carboxamide
CAS No.	1447608-16-3
Molecular Formula	C18H13BrN2O3
Molecular Weight	385.21 g/mol
Synonyms	7-Bromo-1-(4-hydroxy-2-methylphenyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide; 1,4-Dihydro-7-bromo-1-(4-hydroxy-2-methylphenyl)-4-oxo-3-quinolinecarboxamide; 3-Quinolinecarboxamide, 1,4-dihydro-7-bromo-1-(4-hydroxy-2-methylphenyl)-4-oxo-; 1447608-16-3; 7-Bromo-1-(4-hydroxy-o-tolyl)-4-oxo-1,4-dihydroquinoline-3-carboxamide; 7-Bromo-1-(4-hydroxy-2-methylphenyl)-1,4-dihydro-4-oxoquinoline-3-carboxamide
EINECS	Contact for details

Quality Control

Our 7-Bromo-1-(4-Hydroxy-2-Methylphenyl)-4-Oxo-1,4-Dihydroquinoline-3-Carboxamide is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods, to ensure it meets the high standards required for pharmaceutical R&D. A comprehensive Certificate of Analysis (COA) detailing purity, impurities, and analytical results is provided with each shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). This material is light-sensitive (store away from light). Keep away from incompatible materials.

Specification

Item	Specification
Appearance	Off-white to light yellow powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Related Substances (HPLC)	Any individual impurity ≤ 0.5%
Total Impurities	≤ 2.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.